The rational use of antidepressants: Treating the whole patient;Racionalna primjena antidepresiva: Cjelovit pristup bolesniku

Medicus

Volumn 13, Issue 1, 2004, Pages 41-48

  Jakovijević, Miro ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Antidepressants; Effectiveness; Efficacy; Efficiency; Phases of treatment; Rational use

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; CYTOCHROME; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; MAPROTILINE; MONOAMINE NEURONAL REUPTAKE TRANSPORTER; NEUROTRANSMITTER RECEPTOR; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; REBOXETINE; RECEPTOR SUBTYPE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; UNCLASSIFIED DRUG;

ALGORITHM; ANXIETY DISORDER; COST BENEFIT ANALYSIS; DEPRESSION; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HUMAN; MAINTENANCE THERAPY; MONOAMINERGIC SYSTEM; PROPHYLAXIS; RECEPTOR AFFINITY; RECURRENT DISEASE; RELAPSE; REVIEW; SIDE EFFECT;

EID: 14544291399     PISSN: 1330013X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. JAKOVLJEVIĆ M. Liječenje afektivnih psihoza i drugih poremećaja raspoloženja. U: Lokar J, ur. Klinička psihofarmakoterapija. Beograd - Zagreb: Medicinska knjiga; 1990, str. 214-42.
2. JAKOVLJEVIĆ M, DODIG G, UUBIČIĆ crossed D sign, MARIĆ M. Drug treatment of affective disorders. Psychiatria Danubina 1992;4:49-72.
3. JAKOVLJEVIĆ M, FILAKOVIĆ M, LJUBIČIĆ crossed D sign. Treatment of affective disorders resistant to standard psychopharmacotherapy. Psyhiatria Danubina 1992;4:119-26.
4. JAKOVLJEVIĆ M. Antidepresivi: Dileme, mitovi i činjenice. Medicus 1998;7:71-82.
5. GHODSE H. Rational prescribing of psychotropic medecines. International Psychiatry 2004;5:1-2.
6. GOTLIEB IH, HAMMEN CL, ur. Handbook of depression. New York: The Guilford Press; 2002.
7. JAKOVLJEVIĆ M. Depresivni poremećaji: Od ranog prepoznavanja do uspješnog liječenja. Zagreb: Pro mente; 2004.
8. COOKSON J, TAYLOR D, KATONA C. Use of Drugs in Psychiatry. 5. izd. Gaskel: The Royal College of Psychiatrists; 2002.
9. KENNEDY SH, LAM RW, NUTT DJ, THASE ME. Treating depression effectively: applying clinical guidelines. London & New York: Martin Dunitz; 2004.
10. ZOLI S. Što je depresija i kako se liječi? - I izbavi me od mračnog zla. Razgovor s Giovannijem B. Cassanom. Jastrebarsko: Naklada Slap; 2002.
11. PRESKORN SH. Outpatient management of depression: A guide for the practitioner. 2. izd. Professional Communications Inc.; 1999.
12. SIROT EJ, ZULINO D. Guide to combination therapy in psychiatry. Hannover: Hannoversche Aerzte-verlags-Union GMBH; 2000.
13. ERNST CL, GOLDBERG J. Antisuicide properties of psychotropic drugs: a critical review. Harw Rev Psychiatry 2004;12:14-41.
14. Den BOER JA, WESTENBERG HGM, ur. Antidepressants: Selectivity or Multiplicity? Benecke N.I.: Amsterdam; 2001.
15. KELTNER NL, FOLKS DG. Psychotropic Drugs. 3. izd. St. Louis: Mosby, A Harcourt Health Service Company; 2001.
16. MANJI HK, DUMAN RS. Impairment of neuroplasticity and cellular resilience in severe mood disorders: implications for the novel therapeutics. Psychopharmacol Bull 2001;35:5-49.
17. MANJI HK, QUIROZ JA, SPORN J i sur. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol Psychiatry 2003;53:707-42.
18. SAYERS SL. Depression and heart disease. Psychiatric Annals 2004;34:282-8.